128 related articles for article (PubMed ID: 3002577)
1. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS).
Fisher ER; Sass R; Fisher B; Wickerham L; Paik SM
Cancer; 1986 Jan; 57(2):197-208. PubMed ID: 3002577
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators.
Fisher ER; Leeming R; Anderson S; Redmond C; Fisher B
J Surg Oncol; 1991 Jul; 47(3):139-47. PubMed ID: 1649353
[TBL] [Abstract][Full Text] [Related]
3. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.
Fisher ER; Dignam J; Tan-Chiu E; Costantino J; Fisher B; Paik S; Wolmark N
Cancer; 1999 Aug; 86(3):429-38. PubMed ID: 10430251
[TBL] [Abstract][Full Text] [Related]
4. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
5. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity.
Fisher ER; Sass R; Fisher B; Gregorio R; Brown R; Wickerham L
Cancer; 1986 May; 57(9):1717-24. PubMed ID: 2856856
[TBL] [Abstract][Full Text] [Related]
6. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
[TBL] [Abstract][Full Text] [Related]
7. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
8. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.
Lagios MD; Margolin FR; Westdahl PR; Rose MR
Cancer; 1989 Feb; 63(4):618-24. PubMed ID: 2536582
[TBL] [Abstract][Full Text] [Related]
9. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
[TBL] [Abstract][Full Text] [Related]
10. Axillary recurrence in DCIs: is axillary lymphadenectomy warranted?
Trisal V; Qian D; Wagman LD
Am Surg; 2004 Oct; 70(10):876-80. PubMed ID: 15529841
[TBL] [Abstract][Full Text] [Related]
11. Is sentinel node biopsy necessary in conservatively treated DCIS?
Julian TB; Land SR; Fourchotte V; Haile SR; Fisher ER; Mamounas EP; Costantino JP; Wolmark N
Ann Surg Oncol; 2007 Aug; 14(8):2202-8. PubMed ID: 17534687
[TBL] [Abstract][Full Text] [Related]
12. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
15. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
16. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
[TBL] [Abstract][Full Text] [Related]
17. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
[TBL] [Abstract][Full Text] [Related]
18. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
19. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
20. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.
Vicini FA; Recht A
J Clin Oncol; 2002 Jun; 20(11):2736-44. PubMed ID: 12039936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]